NCT00684996 2014-05-15
Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer
National Cancer Institute (NCI)
Phase 1/2 Terminated
Clinical Trials
3 trialsNCT00027729 2013-06-05
Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Phase 1/2 Completed
NCT00284817 2008-05-29
Phase I Study of MEDI522 in Patients With Irinotecan-Refractory Advanced Colorectal Cancer
MedImmune LLC
Phase 1/2 Completed